Molecular screening brings new and different technologies into the newborn screening (NBS)laboratory, creating a need for related resources. APHL collaborates with CDC's Newborn Screening and Molecular Biology Branch (NSMBB) to provide state newborn screening programs with information on available molecular methods and quality improvement activities.
NBS Molecular Methods
The state NBS laboratory assays list (access restricted to NBS lab directors and their delegates) explains how newborn screening programs use their molecular assays and allows users to search for the molecular assay that best fits their needs.
The links below offer information on the use of automation in newborn screening programs, types of automation instruments and considerations in purchasing a liquid handler:
Molecular Assessment Program Quality Improvement
The Molecular Assessment Program (MAP) is a non-regulatory
site visit offered by CDC and APHL that is tailored to
newborn screening laboratories that perform molecular tests. MAP was
developed to assist newborn screening laboratories to determine how to best
meet their molecular testing needs with available resources.
MAP teams are comprised of CDC and state public health laboratory
scientists who work with laboratory personnel to assess all molecular
testing procedures. Visits are tailored to the specific needs of the program and provide guidance on evaluating ongoing or soon-to-be implemented molecular testing procedures.
Read the MAP Testimonials to learn how other labs have benefited from this program.
Interested in participating?Request a MAP Visit
Before the visit:
After the visit:
- Rate your MAP visit.
- The laboratory director will receive a
summary report and any resources related to specific molecular testing
issues that were discussed during the visit.
For more information or questions about MAP, please contact Guisou Zarbalian, MS, MPH, manager, Newborn Screening & Genetics, or Christopher Greene, PhD, research scientist, CDC-NSMBB.
Other Molecular Training Resources
Frequently Asked Questions
NBS Molecular FAQs
For more information about these molecular resources, contact Funke Akinsola, specialist, Newborn Screening & Genetics (240.485.2714) or Laura Hancock, MS, Research Scientist, Newborn Screening and Molecular Biology Branch, CDC.